<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38693285</PMID><DateCompleted><Year>2024</Year><Month>05</Month><Day>01</Day></DateCompleted><DateRevised><Year>2024</Year><Month>05</Month><Day>17</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Apr</Month><Day>30</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Post-Covid-19 condition (Long Covid) in children and young people 12 months after infection or reinfection with the Omicron variant: a prospective observational study.</ArticleTitle><Pagination><StartPage>9957</StartPage><MedlinePgn>9957</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">9957</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-024-60372-4</ELocationID><Abstract><AbstractText>Our previous study in children and young people (CYP) at 3- and 6-months post-infection showed that 12-16% of those infected with the Omicron (B.1.1.529) variant of SARS-CoV-2 met the research definition of Long Covid, with no differences between first-positive and reinfected CYP. The primary objective of the current study is to explore the impact of the Omicron variant of SARS-CoV-2 infection on young people 12 months post infection. 345 CYP aged 11-17&#xa0;years with a first laboratory-confirmed infection with the Omicron variant and 360 CYP reinfected with the Omicron variant completed an online questionnaire assessing demographics, symptoms, and their impact shortly after testing and again at 3-, 6-and 12-months post-testing. Vaccination status was determined from information held at UKHSA. Comparisons between groups were made using chi-squared, Mann-Whitney U, and Kruskal-Wallis tests. The most common symptoms in first-positive and reinfected CYP 12-months post-testing were tiredness (35.7 and 33.6% respectively) and sleeping difficulties (27.5 and 28.3% respectively). Symptom profiles, severity and impact were similar in the two infection status groups. Overall, by 12-months, 17.4% of first-positives and 21.9% of reinfected CYP fulfilled the research consensus Long Covid definition (p&#x2009;=&#x2009;0.13). 12-months post Omicron infection, there is little difference between first-positive and reinfected CYP with respect to symptom profiles and impact. Clinicians may not therefore need to consider number of infections and type of variant when developing treatment plans. Further studies are needed to assess causality of reported symptoms up to 12-months after SARS-CoV-2 infection.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pinto Pereira</LastName><ForeName>Snehal M</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Division of Surgery and Interventional Science, Faculty of Medical Sciences, University College London, Gower Street, London, WC1E 6BT, UK. snehal.pereira@ucl.ac.uk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nugawela</LastName><ForeName>Manjula D</ForeName><Initials>MD</Initials><AffiliationInfo><Affiliation>UCL Great Ormond Street Institute of Child Health, University College London, 30 Guilford Street, London, WC1N 1EH, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stephenson</LastName><ForeName>Terence</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>UCL Great Ormond Street Institute of Child Health, University College London, 30 Guilford Street, London, WC1N 1EH, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Foret-Bruno</LastName><ForeName>Paul</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>UCL Great Ormond Street Institute of Child Health, University College London, 30 Guilford Street, London, WC1N 1EH, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institut de Psychologie, Universit&#xe9; Lumi&#xe8;re Lyon 2, 18 Quai Claude Bernard, 69365, Lyon Cedex 07, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dalrymple</LastName><ForeName>Emma</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>UCL Great Ormond Street Institute of Child Health, University College London, 30 Guilford Street, London, WC1N 1EH, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Laila</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>UCL Great Ormond Street Institute of Child Health, University College London, 30 Guilford Street, London, WC1N 1EH, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Whittaker</LastName><ForeName>Elizabeth</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Section of Paediatric Infectious Diseases, Imperial College London, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Paediatric Infectious Diseases, Imperial College Healthcare NHS Trust, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Heyman</LastName><ForeName>Isobel</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>UCL Great Ormond Street Institute of Child Health, University College London, 30 Guilford Street, London, WC1N 1EH, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ford</LastName><ForeName>Tamsin</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, University of Cambridge, Hershel Smith Building Cambridge Biomedical Campus, Cambridge, CB2 0SZ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Segal</LastName><ForeName>Terry</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>University College London Hospitals NHS Foundation Trust, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chalder</LastName><ForeName>Trudie</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King's College London, De'Crespigny Park, London, SE5 8AF, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ladhani</LastName><ForeName>Shamez N</ForeName><Initials>SN</Initials><AffiliationInfo><Affiliation>Immunisations and Vaccine Preventable Diseases, UK Health Security Agency, 61 Colindale Avenue, London, NW9 5EQ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mensah</LastName><ForeName>Anna A</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Immunisations and Vaccine Preventable Diseases, UK Health Security Agency, 61 Colindale Avenue, London, NW9 5EQ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McOwat</LastName><ForeName>Kelsey</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Immunisations and Vaccine Preventable Diseases, UK Health Security Agency, 61 Colindale Avenue, London, NW9 5EQ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Simmons</LastName><ForeName>Ruth</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Immunisations and Vaccine Preventable Diseases, UK Health Security Agency, 61 Colindale Avenue, London, NW9 5EQ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>CLoCk Consortium</CollectiveName></Author><Author ValidYN="Y"><LastName>Shafran</LastName><ForeName>Roz</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>UCL Great Ormond Street Institute of Child Health, University College London, 30 Guilford Street, London, WC1N 1EH, UK. r.shafran@ucl.ac.uk.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>04</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><SupplMeshList><SupplMeshName Type="Organism" UI="C000711908">SARS-CoV-2 variants</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000084063" MajorTopicYN="Y">Reinfection</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Long Covid</Keyword><Keyword MajorTopicYN="N">Omicron</Keyword><Keyword MajorTopicYN="N">Post Covid-19 condition</Keyword><Keyword MajorTopicYN="N">Prospective</Keyword><Keyword MajorTopicYN="N">Young people</Keyword></KeywordList><CoiStatement>Terence Stephenson is Chair of the Health Research Authority and therefore recused himself from the Research Ethics Application. Tamsin Ford&#x2019;s research group receives funding from Place2Be, a third sector organisation delivering mental health training and interventions in schools, for research methods consultation. The remaining authors report no other conflicts of interest.</CoiStatement><InvestigatorList><Investigator ValidYN="Y"><LastName>Buszewicz</LastName><ForeName>Marta</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Crawley</LastName><ForeName>Esther</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Garg</LastName><ForeName>Shruti</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hargreaves</LastName><ForeName>Dougal</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Harnden</LastName><ForeName>Anthony</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Levin</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Poustie</LastName><ForeName>Vanessa</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Semple</LastName><ForeName>Malcolm</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sharma</LastName><ForeName>Kishan</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>De Stavola</LastName><ForeName>Bianca</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Swann</LastName><ForeName>Olivia</ForeName><Initials>O</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>12</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>4</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>5</Month><Day>2</Day><Hour>0</Hour><Minute>49</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>5</Month><Day>2</Day><Hour>0</Hour><Minute>48</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>5</Month><Day>1</Day><Hour>23</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>4</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38693285</ArticleId><ArticleId IdType="pmc">PMC11063180</ArticleId><ArticleId IdType="doi">10.1038/s41598-024-60372-4</ArticleId><ArticleId IdType="pii">10.1038/s41598-024-60372-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Stephenson T, et al. Long COVID (post-COVID-19 condition) in children: A modified Delphi process. Arch. Dis. Child. 2022;107:674&#x2013;680. doi: 10.1136/archdischild-2021-323624.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/archdischild-2021-323624</ArticleId><ArticleId IdType="pmc">PMC8983414</ArticleId><ArticleId IdType="pubmed">35365499</ArticleId></ArticleIdList></Reference><Reference><Citation>Astin R, et al. Long COVID: Mechanisms, risk factors and recovery. Exp. Physiol. 2023;108:12&#x2013;27. doi: 10.1113/EP090802.</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/EP090802</ArticleId><ArticleId IdType="pmc">PMC10103775</ArticleId><ArticleId IdType="pubmed">36412084</ArticleId></ArticleIdList></Reference><Reference><Citation>ONS. New-Onset, Self-Reported Long COVID after Coronavirus (COVID-19) Reinfection in the UK: 23 February 2023. https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/newonsetselfreportedlongcovidaftercoronaviruscovid19reinfectionintheuk/23february2023 (2023).</Citation></Reference><Reference><Citation>Behnood S, et al. Symptoms persisting for 12 weeks or more after SARS-CoV-2 infection among children and young people: A systematic review and meta-analysis of controlled studies. PLoS One. 2023;18(12):e0293600. doi: 10.1371/journal.pone.0293600.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0293600</ArticleId><ArticleId IdType="pmc">PMC10754445</ArticleId><ArticleId IdType="pubmed">38153928</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng Y-B, et al. Prevalence and risk factor for long COVID in children and adolescents: A meta-analysis and systematic review. J. Infect. Public Health. 2023;16:660&#x2013;672. doi: 10.1016/j.jiph.2023.03.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jiph.2023.03.005</ArticleId><ArticleId IdType="pmc">PMC9990879</ArticleId><ArticleId IdType="pubmed">36931142</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO. A Clinical Case Definition for Post COVID-19 Condition in Children and Adolescents by Expert Consensus. https://www.who.int/publications/i/item/WHO-2019-nCoV-Post-COVID-19-condition-CA-Clinical-case-definition-2023-1 (2023).</Citation></Reference><Reference><Citation>Chaichana U, et al. Definition of post&#x2013;COVID-19 condition among published research studies. JAMA Netw. Open. 2023;6:e235856. doi: 10.1001/jamanetworkopen.2023.5856.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2023.5856</ArticleId><ArticleId IdType="pmc">PMC10077105</ArticleId><ArticleId IdType="pubmed">37017970</ArticleId></ArticleIdList></Reference><Reference><Citation>ONS. COVID-19 Schools Infection Survey, England: Pupil Antibody Data and Vaccine Sentiment, March to April 2022. https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/covid19schoolsinfectionsurveyengland/pupilantibodiesandvaccinesentimentmarch2022 (2022).</Citation></Reference><Reference><Citation>Di Pietro G. The impact of Covid-19 on student achievement: Evidence from a recent meta-analysis. Educ. Res. Rev. 2023;39:100530. doi: 10.1016/j.edurev.2023.100530.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.edurev.2023.100530</ArticleId><ArticleId IdType="pmc">PMC10028259</ArticleId><ArticleId IdType="pubmed">36987429</ArticleId></ArticleIdList></Reference><Reference><Citation>Stephenson T, et al. Long COVID and the mental and physical health of children and young people: National matched cohort study protocol (the CLoCk study) BMJ Open. 2021;11:e052838. doi: 10.1136/bmjopen-2021-052838.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2021-052838</ArticleId><ArticleId IdType="pmc">PMC8392739</ArticleId><ArticleId IdType="pubmed">34446502</ArticleId></ArticleIdList></Reference><Reference><Citation>Stephenson T, et al. Physical and mental health 3 months after SARS-CoV-2 infection (long COVID) among adolescents in England (CLoCk): A national matched cohort study. Lancet Child Adolesc. Health. 2022;6:230&#x2013;239. doi: 10.1016/S2352-4642(22)00022-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-4642(22)00022-0</ArticleId><ArticleId IdType="pmc">PMC8820961</ArticleId><ArticleId IdType="pubmed">35143770</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinto Pereira SM, et al. Natural course of health and well-being in non-hospitalised children and young people after testing for SARS-CoV-2: A prospective follow-up study over 12 months. Lancet Reg. Health Eur. 2023;25:100554. doi: 10.1016/j.lanepe.2022.100554.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2022.100554</ArticleId><ArticleId IdType="pmc">PMC9719829</ArticleId><ArticleId IdType="pubmed">36504922</ArticleId></ArticleIdList></Reference><Reference><Citation>Stephenson T, et al. Long COVID&#x2014;six months of prospective follow-up of changes in symptom profiles of non-hospitalised children and young people after SARS-CoV-2 testing: A national matched cohort study (The CLoCk) study. PLoS One. 2023;18:e0277704. doi: 10.1371/journal.pone.0277704.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0277704</ArticleId><ArticleId IdType="pmc">PMC9987792</ArticleId><ArticleId IdType="pubmed">36877677</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinto Pereira SM, et al. Post-COVID-19 condition at 6 months and COVID-19 vaccination in non-hospitalised children and young people. Arch. Dis. Child. 2023;108:289&#x2013;295. doi: 10.1136/archdischild-2022-324656.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/archdischild-2022-324656</ArticleId><ArticleId IdType="pmc">PMC10086284</ArticleId><ArticleId IdType="pubmed">36599625</ArticleId></ArticleIdList></Reference><Reference><Citation>Nugawela MD, et al. Predictive model for long COVID in children 3 months after a SARS-CoV-2 PCR test. BMC Med. 2022;20:465. doi: 10.1186/s12916-022-02664-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-022-02664-y</ArticleId><ArticleId IdType="pmc">PMC9708506</ArticleId><ArticleId IdType="pubmed">36447237</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahase E. Covid-19: How many variants are there, and what do we know about them?: Video 1. BMJ. 2021 doi: 10.1136/bmj.n1971.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1971</ArticleId><ArticleId IdType="pubmed">34413059</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonelli M, Pujol JC, Spector TD, Ourselin S, Steves CJ. Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2. Lancet. 2022;399:2263&#x2013;2264. doi: 10.1016/S0140-6736(22)00941-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)00941-2</ArticleId><ArticleId IdType="pmc">PMC9212672</ArticleId><ArticleId IdType="pubmed">35717982</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinto Pereira SM, et al. Long COVID in children and young after infection or reinfection with the omicron variant: A prospective observational study. J. Pediatr. 2023;259:113463. doi: 10.1016/j.jpeds.2023.113463.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpeds.2023.113463</ArticleId><ArticleId IdType="pmc">PMC10171900</ArticleId><ArticleId IdType="pubmed">37172813</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravens-Sieberer U, et al. Feasibility, reliability, and validity of the EQ-5D-Y: Results from a multinational study. Qual. Life Res. 2010;19:887&#x2013;897. doi: 10.1007/s11136-010-9649-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11136-010-9649-x</ArticleId><ArticleId IdType="pmc">PMC2892614</ArticleId><ArticleId IdType="pubmed">20401552</ArticleId></ArticleIdList></Reference><Reference><Citation>ter Wolbeek M, van Doornen LJP, Kavelaars A, Heijnen CJ. Severe fatigue in adolescents: A common phenomenon? Pediatrics. 2006;117:e1078&#x2013;e1086. doi: 10.1542/peds.2005-2575.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2005-2575</ArticleId><ArticleId IdType="pubmed">16740810</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinto Pereira SM, et al. Symptom profiles of children and young people 12 months after SARS-CoV-2 testing: A National Matched Cohort Study (The CLoCk Study) Children. 2023;10:1227. doi: 10.3390/children10071227.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/children10071227</ArticleId><ArticleId IdType="pmc">PMC10377812</ArticleId><ArticleId IdType="pubmed">37508724</ArticleId></ArticleIdList></Reference><Reference><Citation>Institute for Government. Timeline of UK government coronavirus lockdowns and measures, March 2020 to December 2021. https://www.instituteforgovernment.org.uk/sites/default/files/timeline-coronavirus-lockdown-december-2021.pdf (2021).</Citation></Reference><Reference><Citation>Rojas NK, et al. Developing survey weights to ensure representativeness in a national, matched cohort study: Results from the Children and young people with Long Covid (CLoCk) study. Res. Sq. 2023 doi: 10.21203/rs.3.rs-2912362/v1.</Citation><ArticleIdList><ArticleId IdType="doi">10.21203/rs.3.rs-2912362/v1</ArticleId><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>